Andrew Makrides - 05 Jul 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Andrew Makrides
Issuer symbol
APYX
Transactions as of
05 Jul 2022
Net transactions value
-$7,200
Form type
4
Filing time
11 Jul 2022, 15:54:13 UTC
Previous filing
11 Aug 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $76,200 +30,000 +4.9% $2.54 637,972 05 Jul 2022 Direct
transaction APYX Common Stock Tax liability $83,400 -13,583 -2.1% $6.14 624,389 05 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Options Exercise $0 -30,000 -100% $0.000000* 0 05 Jul 2022 Common Stock 30,000 $2.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options.
F2 Reporting Person was granted a stock option that vested and became exercisable over 5 years at a rate of 20% of the option on the anniversary date of each year.